Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Hematology/Oncology Clinics of North America|November 30, 1999
Autologous transplantation. Purging and the impact of minimal residual diseaseR Vescio, J BerensonCurrent Opinion in Hematology|July 1, 1995
Multiple myeloma and chronic lymphocytic leukemiaL Rosen, R Vescio, J R BerensonSeminars in Oncology|December 12, 2001
The role of nuclear factor-kappaB in the biology and treatment of multiple myelomaJ R Berenson, H M Ma, R VescioCurrent Opinion in Hematology|July 1, 1996
Multiple myeloma and chronic lymphocytic leukemiaR Vescio, L Rosen, E Schmulbach, et al.Cellular Immunology|May 1, 1995
Interleukin-6 inhibits apoptosis of malignant plasma cellsA Lichtenstein, Y Tu, C Fady, et al.Blood|September 1, 1996
Upregulated expression of BCL-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxideY Tu, F H Xu, J Liu, et al.Bone Marrow Transplantation|July 1, 1994
Phase I-II study of busulfan and cyclophosphamide conditioning for transplantation in advanced multiple myelomaG Schiller, S Nimer, R Vescio, et al.British Journal of Haematology|January 1, 1997
Analysis of the p16INK4A, p15INK4B and p18INK4C genes in multiple myelomaT Tasaka, J Berenson, R Vescio, et al.Cancer|January 10, 2001
A Phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone diseaseJ R Berenson, R Vescio, K Henick, et al.Journal of Clinical Pharmacology|April 1, 1997
Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal functionJ R Berenson, L Rosen, R Vescio, et al.Pageof 3